From the US perspective, model 1 showed significant differences among subgroups with different ages, sex, ECOG performance status, smoking histories, LDH concentration at enrollment, status of liver metastases, and PD-L1 tumor proportion scores (p < 0.05). This evidence concerns the gene CD274 and neoplasm.